Procurement of HPV Vaccine Plagued by Protests from Pharma Companies
Ljubljana, 24 August - The Institute for Public Health (IVZ) is looking at what will likely be the third unsuccessful attempt to procure a supply of human papillomavirus (HPV) vaccines, as pharma company GlaxoSmithKline (GSK) filed a protest over what it called a non-transparent procurement process.
The rest of this news item is available to subscribers.
The news item consists of 1.067 characters (without spaces) or 216 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.